|
Device Problems
Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the resolute integrity rx coronary drug-eluting stent.Survey results from an interventional cardiologist in practice 15 years.In the past 12 months, the physician has used the resolute integrity stent 300 times and intermediate (2.25 x 12 mm to 4.00 x 34 mm) sizes of these stents were used.The following device complaints were encountered in procedure when using the resolute integrity product over the last 12 months: 25 cases of deployment difficulties were reported to have occurred and had no clinical/patient impact.4 cases of stent deformation (in vivo) were reported to have occurred and had no clinical/patient impact.
|
|
Manufacturer Narrative
|
Additional information: the physician in this case consented to participate in the survey but did not consent to be contacted regarding the information provided and wished to remain anonymous, therefore information for facility and city cannot be provided.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|